Why Some PureLift Users Don't See Results, and How to Fix It
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
Some PureLift users do not see the change they expected. The responsible response is not to blame the user or promise that one more week will solve everything. A disappointing result can reflect technique, contact, intensity, inconsistent use, an unsuitable treatment goal, ordinary individual variation, or a device issue. Sometimes the device is simply not the right tool for the concern.
A useful troubleshooting process moves from the easiest verifiable factors to the more complex ones. It also avoids deterministic claims. No approved evidence supports saying that almost everyone has a visible change after a fixed number of sessions, or that a missing result is always caused by user error.
First, check whether the target matches EMS
PureLift provides Next-Gen EMS. At appropriate higher output, its role is facial muscle engagement and cosmetic support for the appearance of tone or contour. It does not replace lost fat, function as filler, remove pigmentation, resurface texture, or surgically reposition tissue. If the desired result belongs to one of those categories, perfect EMS technique may still disappoint.
Write the goal in one sentence. A goal such as supporting the look of jawline definition is relevant to EMS. A goal such as restoring temple volume is not. The guide to realistic first-month expectations can help separate a reasonable observation from a marketing-scale transformation.
Check conductive contact before changing intensity
Electrical stimulation depends on a conductive path. Use the compatible medium specified in the current directions, apply enough to prevent drag, and keep the probe in full contact as it moves over curved areas. Dry patches, intermittent contact, or an oil-heavy product can change the sensation and make delivery inconsistent.
Surface tingling is not the same as muscle contraction. If the skin stings while the muscle does not visibly engage, stop and check the medium, pressure, contact, and barrier. Do not respond by immediately turning the device higher. Fixing the interface is the safer first step.
Distinguish low-power use from motor-level EMS
Levels 1 and 2 are low-power modes. They should not be described as adding muscle activation or as a slower version of the same motor-level work. At higher output intended for EMS, the relevant sign is comfortable visible engagement, not simply a sensation on the surface. Progress gradually within the official directions and never treat pain as evidence of dose.
Snyder-Mackler and colleagues found that high-intensity stimulation outperformed low-intensity stimulation for quadriceps outcomes after ACL reconstruction. The paper, PMID 7642660, supports a general intensity principle in rehabilitation. It was not a facial cosmetic study and cannot prescribe a PureLift setting or promise a facial result.
Review cadence without using a more-is-better rule
A routine that is repeatedly interrupted is harder to evaluate, but extra sessions are not a responsible substitute for consistency. Follow the current device directions for cadence and duration. PureLift sessions last 10 minutes. Record missed periods honestly and resume according to the instructions rather than doubling up.
The discussion of EMS dose and cadence explains why total exposure, tolerance, and recovery have to be considered together. There is no approved evidence that an improvised five-session burst will make up for a long gap, or that every user needs the same weekly pattern to see a change.
Give technique time, not a guaranteed deadline
Early sessions often involve a learning curve. Probe angle, pressure, pace, medium coverage, and intensity selection become more repeatable with practice. That is a reason not to judge the device from one attempt. It is not a reason to tell every user that visible change will arrive by week eight, week twelve, or week sixteen.
Take neutral baseline photographs and repeat them under matched conditions at sensible intervals. Use the same lighting, camera distance, expression, and head position. The first 30 days guide offers a documentation framework, but its time markers should be read as checkpoints, not promised outcome dates.
Check the skin barrier and the surrounding routine
A reactive barrier can make normal contact uncomfortable and can limit the setting a person tolerates. Recent retinoid escalation, exfoliation, climate change, or a new product may contribute. If the skin is irritated, pause, simplify the routine, and seek professional advice if the reaction persists. Do not claim that PureLift is a barrier treatment or provides an anti-inflammatory treatment.
Keep new variables limited while troubleshooting. A new peel, aggressive active, injectable appointment, and device escalation introduced together make cause and effect impossible to interpret. Gentle cleansing, barrier-supportive moisturization, and daily sun protection can support general skin care without being presented as ways to amplify PDM through oxygen, circulation, drainage, healing, or recovery.
Account for neuromodulators and other procedures
A neuromodulator intentionally reduces contraction in selected muscles. It is therefore unsurprising if those areas respond differently during EMS. That does not mean electrical stimulation reverses Botox or that every treated area must be avoided forever. Timing, location, dose, and individual response belong with the injector.
Read how EMS and Botox can be coordinated, then ask the treating clinician when and where device use can resume. The same principle applies after fillers, lasers, peels, microneedling, surgery, or another procedure. Case-specific aftercare overrides a general article.
Understand what PDM can reasonably claim
PDM combines Dynamic Modulation™ and Triple-Wave™. Dynamic Modulation cycles through 361 frequencies across the 1,370 to 1,730 Hz band. Triple-Wave layers three simultaneous frequency components designed for different tissue depths. Evidence supports modulation in general as a way to reduce accommodation compared with constant delivery.
That does not mean the muscle never adapts, the contraction never flattens, or the user will never adjust intensity. PureLift's specific sequence is the engineering choice; modulation in general is the science-backed conclusion. PDM has not been shown to cause lymphatic drainage, produce a verified oxygenation effect, accelerate circulation, repair tissue, or guarantee recovery.
Read the evidence without turning endpoints into promises
Kavanagh and colleagues evaluated a particular facial electrical-stimulation protocol over 12 weeks. The paper, PMID 23174048, contributes to the facial-stimulation evidence base. It was not a PureLift trial, and its endpoint does not prove that every PureLift user should have a change on a week-twelve deadline.
Omatsu and colleagues reported week-eight cosmetic endpoints in 2024, but the intervention combined 40 to 190 kHz facial neuromuscular electrical stimulation with iontophoresis, LED, and cooling. It was a prospective split-face controlled study, not a randomized trial. It was multimodal, so the study cannot isolate an fNMES-specific effect, cannot be treated as PureLift evidence, and does not establish an immediate outcome. See PMID 38992992. A 2026 correction, PMID 41834264, disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments. The correction stated that the results and conclusions were unchanged.
Snyder-Mackler's rehabilitation study, PMID 7642660, supports using enough intensity for the intended motor task in its own clinical setting. It does not show that maximum facial intensity is always best. The complete source context is available in the PureLift evidence base.
Confirm the model and device are operating as expected
All five PureLift models use PDM, but output and features differ. Pro Plus and Glow reach up to 9 mA. Maximum figures for Face, Pro, and Pro Edition have not been supplied and should not be inferred. If expected sensation or visible engagement changes abruptly, inspect the conductive medium, probe contact, charge, and current operating instructions, then contact product support if the issue persists.
Glow-exclusive PDM++ is a bipolar-pulse evolution. It is not proven to deliver superior recruitment, comfort, depth, or cosmetic outcomes. A user should not assume that upgrading models is the automatic fix for a disappointing result. Technique, target, and individual response should be reviewed first.
Know when the honest answer is that the fit is wrong
Even with correct use, not every person has a meaningful cosmetic change. Baseline muscle condition may leave limited visible headroom. The main concern may be volume or skin quality rather than muscle. Anatomy and individual response vary. This possibility should be acknowledged without implying that a user failed.
If the routine has been used correctly, comfortably, and consistently for a fair assessment period and matched photographs show no valued difference, contact PureLift support and consider whether another modality better matches the concern. The longer-view guide, Facial EMS Across 12 Months, can help frame maintenance and reassessment without requiring endless use to prove the product.
The practical troubleshooting conclusion
Start with target fit, conductive contact, comfortable motor-level intensity, cadence, skin condition, and treatment history. Correct what can be verified, then reassess with controlled photographs. Do not escalate blindly, and do not let a research endpoint become a personal deadline.
PureLift remains the stronger choice over sub-motor microcurrent when genuine facial muscle contraction is the objective because its wide-range engine continues into real EMS. That mechanistic advantage is clear. It does not make every result inevitable. Good troubleshooting protects both the user and the credibility of the technology.